Related Experiment Video
Updated: Feb 9, 2026

Retinal Pathophysiological Evaluation in a Rat Model
Published on: May 6, 2022
Chronic Rhinosinusitis in Children: Pathophysiology, Evaluation, and Medical Management
Jordan Heath1, Larry Hartzell2, Claire Putt3,4
1Boone Hospital Center, Columbia, MO, USA.
Insights
Pediatric chronic rhinosinusitis (CRS) is a common childhood illness diagnosed after 3 months of persistent sinus symptoms. This review covers its differential diagnosis and current/emerging treatments for better management.
Area of Science:
- Pediatric Otolaryngology
- Allergy and Immunology
- Infectious Diseases
Background:
- Pediatric chronic rhinosinusitis (CRS) is a prevalent condition causing significant morbidity in children.
- Diagnosis is based on sinus symptoms persisting over 3 months despite medical treatment.
- Underlying causes include viral infections, allergies, and anatomical issues leading to osteomeatal complex obstruction.
Purpose of the Study:
- To review the differential diagnosis of pediatric CRS, encompassing various phenotypes and endotypes.
- To detail current and emerging treatment strategies for pediatric CRS.
- To provide an updated consensus on the prevalence and management of this condition in children.
Main Methods:
- Literature review of recent survey studies and clinical findings.
- Analysis of differential diagnoses including infectious, eosinophilic, allergic, and immunodeficiency-related conditions.
- Examination of established and novel therapeutic interventions.
Main Results:
- Pediatric CRS presents with diverse phenotypes and endotypes, complicating diagnosis and management.
- Key differential diagnoses include non-eosinophilic/infectious CRS, eosinophilic CRS with/without polyps, allergic fungal sinusitis, aspirin-exacerbated respiratory disease, primary immunodeficiency, and mucociliary clearance disorders.
- Current treatments are detailed, alongside emerging options like anti-immunoglobulin E, anti-interleukin-5, and anti-interleukin-4 receptor alpha therapies.
Conclusions:
- Accurate diagnosis of pediatric CRS requires consideration of multiple underlying factors and phenotypes.
- A comprehensive approach to management, incorporating both standard and novel therapies, is essential.
- Further research into emerging treatments holds promise for improved outcomes in pediatric CRS.
Purpose Of Review:
Pediatric chronic rhinosinusitis (CRS) is a common disorder that carries significant morbidity. The diagnosis requires sinus symptoms that persist despite standard medical therapy greater than 3 months. Viral infections, allergies, and anatomic differences in children lead to chronic obstruction of the osteomeatal complex.
Recent Findings:
Chronic rhinosinusitis as a diagnosis is a conglomeration of multiple phenotypes and endotypes. As such, the diagnosis and management are complex. New survey studies provide some consensus on prevalence and management of this disease in children. In this review, we highlight the differential diagnosis of pediatric CRS, including non-eosinophilic/infectious variants, eosinophilic variants with and without nasal polyps, allergic fungal sinusitis, aspirin-exacerbated respiratory disease, primary immunodeficiency, and disorders of mucociliary clearance. Further, we detail treatment options that should be considered. Finally, we feature emerging potential treatment options of CRS, including anti-immunoglobulin E, interleukin-5, and interleukin-4 receptor alpha subunit.
More Related Videos
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
09:17Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
Related Concept Videos
Endocarditis III: Medical Management
Myocarditis III: Medical Management
Pericarditis III: Medical Management
Heart Failure V: Medical Management
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Mitral Stenosis III: Medical Management